Pain Research Laboratory, Institute of Nautical Medicine, Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, 226001, China.
Eur J Neurosci. 2014 Apr;39(8):1391-402. doi: 10.1111/ejn.12502. Epub 2014 Feb 12.
Ligustilide (LIG) is a major component of Radix Angelica Sinensis, and reportedly has neuroprotective and anti-inflammatory effects. Recent studies have demonstrated that spinal astrocyte-mediated neuroinflammation plays an important role in the pathogenesis of chronic pain. Here we investigated the anti-nociceptive effect of systemic treatment with LIG on chronic inflammatory pain and explored possible mechanisms. Unilateral hindpaw injection of complete Freund's adjuvant (CFA) induced persistent pain hypersensitivity. Repeated daily intravenous treatment with LIG, either before or after CFA injection, attenuated CFA-induced thermal hyperalgesia and mechanical allodynia. The same treatment also inhibited CFA-induced keratinocyte-derived chemokine (KC) and monocyte chemoattractant protein-1 (MCP-1) mRNA and protein increases in astrocytes of the spinal cord. In vitro study showed LIG dose-dependently reduced lipopolysaccharide (LPS)-induced upregulation of KC and MCP-1 mRNA in astrocyte cultures. Interestingly, LIG treatment did not affect CFA- or LPS-induced glial fibrillary acidic protein upregulation, but did inhibit CFA-induced phosphorylated nuclear factor-κB (p-NFκB) upregulation in spinal astrocytes. Furthermore, intrathecal injection of NFκB inhibitor attenuated CFA-induced pain hypersensitivity and upregulation of KC and MCP-1 in the spinal cord. Finally, single intravenous injection of LIG attenuated intrathecal injection of LPS-induced mechanical allodynia. The same treatment also decreased LPS-induced NFκB activation and KC and MCP-1 upregulation in the spinal cord. These data indicate that LIG attenuates chronic inflammatory pain potentially via inhibiting NFκB-mediated chemokines production in spinal astrocytes. These results provide direct evidence of the anti-nociceptive and anti-inflammatory effects of LIG, suggesting a new application of LIG for the treatment of chronic inflammatory pain.
藁本内酯(LIG)是当归的主要成分,据报道具有神经保护和抗炎作用。最近的研究表明,脊髓星形胶质细胞介导的神经炎症在慢性疼痛的发病机制中起着重要作用。在这里,我们研究了全身给予 LIG 对慢性炎性疼痛的镇痛作用,并探讨了可能的机制。单侧足底注射完全弗氏佐剂(CFA)引起持续性痛觉过敏。在 CFA 注射前或后,重复每日静脉内给予 LIG 治疗可减轻 CFA 诱导的热痛觉过敏和机械性痛觉过敏。相同的治疗还抑制了 CFA 诱导的角质形成细胞衍生趋化因子(KC)和单核细胞趋化蛋白-1(MCP-1)mRNA 和脊髓星形胶质细胞中的蛋白增加。体外研究表明,LIG 呈剂量依赖性地降低脂多糖(LPS)诱导的星形胶质细胞培养物中 KC 和 MCP-1 mRNA 的上调。有趣的是,LIG 处理不影响 CFA 或 LPS 诱导的神经胶质纤维酸性蛋白上调,但抑制 CFA 诱导的脊髓星形胶质细胞中磷酸化核因子-κB(p-NFκB)上调。此外,鞘内注射 NFκB 抑制剂减弱了 CFA 诱导的疼痛过敏和脊髓 KC 和 MCP-1 的上调。最后,单次静脉注射 LIG 减弱了鞘内注射 LPS 引起的机械性痛觉过敏。相同的治疗还降低了 LPS 诱导的 NFκB 激活和脊髓中 KC 和 MCP-1 的上调。这些数据表明,LIG 通过抑制脊髓星形胶质细胞中 NFκB 介导的趋化因子产生来减轻慢性炎性疼痛。这些结果提供了 LIG 具有镇痛和抗炎作用的直接证据,表明 LIG 可用于治疗慢性炎性疼痛。